- The price of Numeraire surged 40% to nearly $12.40 after JPMorgan secured $500 million capacity in Numerai.
- The NMR token jumped to levels last seen in February.
- JPMorgan’s move could more than double Numerai’s size.
Numeraire (NMR), the native token of San Francisco-based crypto hedge fund Numerai, climbed more than 40% in the past 24 hours following an announcement that JPMorgan made a substantial commitment to the fund.
On August 26, the Numerai team announced that JPMorgan had secured $500 million in capacity with Numerai, a development that triggered the strong price surge. The gains outpaced other tokens such as Cronos (CRO), which rose after Trump Media announced a partnership with Crypto.com.
As NMR approached $12.40, Numerai’s daily trading volume jumped by over 800% to more than $115 million. The token reached its highest level since February.
JPMorgan secures $500 million capacity in Numerai hedge fund
As artificial intelligence and decentralized finance converge, the crypto sector is attracting high-profile partnerships. Numerai, a hedge fund built by data scientists in San Francisco, is among the firms benefiting from that trend.
On Tuesday, the platform revealed it had secured a $500 million commitment from JPMorgan Asset Management, after seeing assets under management grow from $60 million to $450 million.
The $500 million allocation follows Numerai’s strong performance in 2024, when it delivered a net return of 25.45% with a Sharpe ratio of 2.75.
As noted in Numerai’s blog, investment from JPMorgan — a major allocator to quantitative strategies globally — signals Wall Street’s increasing confidence in AI-driven financial models.
The hedge fund, which counts support from investors like Paul Tudor Jones, is expected to see its assets under management more than double as a result of this development.
A rally that caught Wall Street’s attention
Numerai’s path has not been without setbacks. The firm lost 17% in 2023, reflecting the struggles of other experimental quant platforms such as Quantopian, which closed in 2020 after failing to sustain returns.
Numerai rebounded in 2024 with a 25% gain and has delivered 15 consecutive months of positive performance.
This turnaround drew interest from institutional investors. “People don’t really invest until there’s a track record,” founder Richard Craib told Bloomberg. “And when you do something very unusual and different, like we do, they may wait even longer before getting excited.”
Through 2025, Numerai’s flagship fund, Numerai One, is estimated to be up roughly 6% net of fees, compared with a 7% return for an index of quantitative equity market-neutral funds tracked by Aurum.
The fund has produced gains in all but one year since inception, including a 20% rally in 2022 when broader markets declined.
Big news for NMR?
Founded in 2019, Numerai operates a unique crowdsourced hedge fund model that leverages AI and data science. The platform allows data scientists worldwide to submit stock market predictions via an API and stake NMR tokens to back their models. Accurate predictions earn rewards, while incorrect forecasts can lead to token burns, creating an active incentive structure.
Numerai recently announced a $1 million buyback of NMR, a move that has resonated with the data science community.
The JPMorgan partnership not only validates Numerai’s vision but also highlights the potential for Numeraire within the crypto-AI space. As the hedge fund plans to scale its team and operations, investor interest in NMR is likely to remain strong, particularly after JPMorgan’s commitment.
NMR’s price previously reached highs above $93 in May 2021 and $25.80 in December 2024.